Global Medical Nutrition Market Size & Growth Overview
Medical Nutrition Market Valued at USD 14.4 billion in 2023, projected to grow from USD 15.1 billion in 2024 to USD 24.99 billion by 2032, at a CAGR of 5.10% during the forecast period (2024 - 2032). Growing prevalence of metabolic disorders, and rising spending healthcare infrastructure across the globe are the key market drivers enhancing the market growth during the forecast period.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
In July 2023, Abbott Nutrition presented a detailed account of the company's involvement in carrying out human clinical trials throughout the Asia-Pacific region. The administration emphasized the necessity of cooperation among crucial parties, including researchers, hospitals, and the industry, for the successful implementation of human clinical trials. Regarding the execution of human clinical trials, a crucial aspect that was emphasized is the importance of teamwork. The objective of this study was to assess the efficacy of the oral nutrition supplement produced by Abbott and marketed as Ensure Life HMB in enhancing the health outcomes of elderly individuals residing in the community and facing the risk of malnutrition. The company is focusing on addressing issues such as sarcopenia, malnutrition among older individuals, and diabetes, as these are key areas of concern due to the increasing popularity of healthy aging as a significant trend.
In September 2023, RxFood Corporation, a company specializing in AI-driven personalized nutrition assessments, and Dexcom, Inc., a global leader in real-time continuous glucose monitoring (rtCGM) for individuals with diabetes, announced a unique partnership in Canada. The purpose of this partnership is to introduce an enhanced digital health solution for people living with diabetes. The collaboration will prioritize the development of an enhanced digital healthcare solution for individuals who have diabetes. The latest version of the RxFood application, which incorporates glucose data from Dexcom CGM devices, is now available to participants in healthcare programs in Canada. The stakeholders encompass clinics, hospitals, health agencies, pharmacies, insurers, and employers. The software is designed to be integrated into diabetes and nutrition control programs.
Medical Nutrition Market Highlighted Trends & Dynamics
- Growing Prevalence of chronic diseases to boost market growth
The prevalence of chronic illnesses like cancer, heart disease, gastrointestinal problems, respiratory diseases, and malnutrition among adults and children is on the rise, as is the need for nutritional support. While frequently seen in the elderly population, oropharyngeal dysphagia is frequently documented in individuals with neurological illnesses such multiple sclerosis, oropharyngeal dysphagia, Parkinson's disease, and dementia.
The condition's swallowing issues are strongly promoting clinical nutrition, especially as the prevalence of neurological illnesses continues to climb globally. According to a WHO report from 2022, there would likely be 78 million people living with dementia in 2030 and 139 million in 2050.
Additionally, during the projected period, manufacturers are anticipated to launch an increasing number of products, fueling the expansion of the worldwide medical nutrition market. For instance, the healthcare business Baxter announced in September 2020 that Clinimax and Clinimax E had been approved by the U.S. FDA (Food and Drug Administration). These Clinimax and Clinimax E injections, which contain amino acids with electrolytes in dextrose and calcium, respectively, are new formulations. These contain more proteins (amino acids), carbohydrates, lipids (fats), electrolytes, vitamins, and other trace components and are intended for patients who need parenteral nourishment to assist prevent malnutrition. Therefore, such medical condition related to the medical nutrition has enhanced the medical nutrition market CAGR across the globe in the recent years.In addition, a sustainable proprietary lactoferrin protein reflecting the nutritional properties of lactoferrin from breast milk was developed in March 2020 by Conagen Inc., a biotechnology company focused on bio-production of ingredients for the food, pharmaceutical, and renewable materials industries. The first of its type lactoferrin protein is created at industrial scale by fermentation. However, to cater the demand there has been significant advances in the treatment innovations is another factor driving the growth of the medical nutrition market revenue.
Medical Nutrition Market Segment Insights
Medical Nutrition Type Insights
The medical nutrition market segmentation, based on type, includes pediatric nutrition, elderly nutrition, parenteral nutrition, and sports nutrition. The pediatric nutrition segment held the majority share in 2021 contribution to around ~30-40% in respect to the medical nutrition market revenue. This is primarily owing to the rising prevalence of chronic disease and rising geriatric population throughout the world.
Medical Nutrition Product Type Insights
The medical nutrition market segmentation, based on product type, includes amino acid solutions, multivitamin supplements, antioxidants, lipid emulsions, trace elements, and chamber beads. The amino acid solutions segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032. Solutions containing amino acids hold the biggest market share. During the projected period, the medical nutrition market for lipid emulsions is expected to rise rapidly. Hence, rising applications of oral diseases for medical nutrition positively impacts the market growth.
Medical Nutrition Route of the Administration Insights
The medical nutrition market data has been bifurcated by route of the administration into oral, parenteral, and intravenous. The oral route of the administration segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032. The demand for oral therapeutic supplements has increased as a result of the growing emphasis on keeping a healthy immune system. The expansion of the oral medical nutrition market will be aided by the use of oral nutrition in the fight against malnutrition.
April 2021: BASF and NutiFood collaborated to create products containing human milk oligosaccharides (HMO). The first Vietnamese dairy company, NutiFood, has partnered with a company in Europe to incorporate HMO into its line of nutritional goods. Oral feeding is a method that these goods can be eaten. This collaboration has further broadened the growth opportunity for the medical nutrition industry.
Figure 2: Medical Nutrition Market, by Route of the Administration, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
However, the parental segment is anticipated to expand quickly over the projection period. One of the main factors anticipated to increase demand for parental nutrition is the increased incidence of childhood malnutrition, particularly in emerging and developing countries around the world.
Medical Nutrition Application Insights
Based on application, the medical nutrition industry has been segmented into pulmonary diseases, cancer, gastrointestinal diseases, obesity, diabetes, pediatric malnutrition, renal failure, and neurological diseases. Cancer held the largest segment share in 2021, owing to the rapid increasing number of various types of cancer patients and supportive government initiatives for patients. Moreover, increasing government initiatives to improve the healthcare infrastructure, and the growing number of medical nutrition treatment segment is expected to bolster at a significant CAGR during the assessed timeline.
The third fastest growing segment in the medical nutrition industry is diabetes. Diabetes is a long-term (chronic) illness that affects how your body converts food into energy which increases the demand for medical nutrition products during the forecast period.
Medical Nutrition Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Medical Nutrition market accounted for USD 19.43 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing incidence of chronic diseases such as cancer, diabetes and others, as well as an ageing population across the region.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: MEDICAL NUTRITION MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe medical nutrition market accounts for the significant market share due to the availability of cutting-edge treatment facilities, government of the European countries are spending on the healthcare industry, and increasing ageing population. Further, the Germany medical nutrition market held the largest market share, and the UK medical nutrition market was the fastest growing market in the European region.
The Asia-Pacific Medical Nutrition Market is expected to grow at the fastest CAGR from 2024 to 2032. This is due to increased rates of geriatric population, the rapidly growing medical tourism industry, and rising healthcare costs. Moreover, China medical nutrition market held the largest market share, and the India medical nutrition market was the fastest growing market in the Asia-Pacific region.
Medical Nutrition Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the medical nutrition market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the medical nutrition industry must offer cost-effective treatments and products to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the medical nutrition industry to benefit patients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, medical nutrition industry has provided medicine with some of the most significant benefits. The medical nutrition market major player such as Solace Nutrition (U.K.), AYMES Nutrition International Ltd. (U.K.), Mead Johnson and Company LLC. (U.S.), Nestle Health Science (Switzerland), Braun Melsungen AG (Germany), NeoMed (U.S.), Abbott Nutrition (U.S.), Baxter International (U.S.), Danone (France), and others are working to expand the market demand by investing in research and development activities.
The medical nutrition company Solace Nutrition has a dedication to developing and providing dependable, effective nutrition solutions that support people with specific dietary needs. Five product lines make up Solace Nutrition's selection of goods. These product lines include NeoKe, NanoVM, Cyto, Metabolics, and SolMods. For instance, in January 2022, R-Kane Nutritionals' assets were purchased by Solace Nutrition, a medical nutrition firm based in the United States, for an undisclosed sum. By acquiring these assets, Solace Nutrition is able to grow its business, strengthen its brand recognition, and establish a foothold in a nearby nutrition market.
Also, AYMES Nutrition International Ltd. (U.K.) creates novel, delicious, and affordable oral nutritional supplements. The business offers a variety of goods to its clients, such as Clinical Nutrition, Oral Nutritional Support, and nutritional supplements. In May 2022, patients can use AYMES ActaGain Juce as a hydrating substitute for milk-based ONS. a practical ready-to-drink dietary supplement for people with disease-related malnutrition or those at risk of it.
Key Companies in the medical nutrition market includes
-
Solace Nutrition (U.K.)
- AYMES Nutrition International Ltd. (U.K.)
- Mead Johnson and Company LLC. (U.S.)
- Nestle Health Science (Switzerland)
- Braun Melsungen AG (Germany)
- NeoMed (U.S.)
- Abbott Nutrition (U.S.)
- Baxter International (U.S.)
- Danone (France), among others
Medical Nutrition Industry Developments
June 2022: The world's top virtual research organisation (VRO), ObvioHealth, has a wealth of clinical, pharmaceutical, biotechnology, and healthcare experience6. It is building ground-breaking end-to-end solutions for remote clinical trials. announced the creation of an advisory council made up of significant business figures.
May 2022: Registered dietitians Steven Kuyan and Vanessa Rissetto launched Culina Health, which has received $ 4.75 million in early funding following 18 months of bootstrap expansion in the practise of 20 doctors who have already held more than 18,000 sessions.
Medical Nutrition Market Segmentation
Medical Nutrition Type Outlook
- Pediatric Nutrition
- Elderly Nutrition
- Parenteral Nutrition
- Sports Nutrition
Medical Nutrition Product Type Outlook
- Amino Acid Solutions
- Multivitamin Supplements
- Antioxidants
- Lipid Emulsions
- Trace Elements
- Chamber Beads
Medical Nutrition Route of the Administration Outlook
- Oral
- Parenteral
- Intravenous
Medical Nutrition Application Outlook
- Pulmonary Diseases
- Cancer
- Gastrointestinal Diseases
- Obesity
- Diabetes
- Pediatric Malnutrition
- Renal Failure
- Neurological Diseases
Medical Nutrition Distribution Channel Outlook
- Compounding Pharmacies
- Hospitals
- Retail Pharmacies
- E-commerce Websites
Medical Nutrition Regional Outlook
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
| Attribute/Metric |
Details |
| Market Size 2023 |
USD 14.4 billion |
| Market Size 2024 |
USD 15.13 billion |
| Market Size 2032 |
USD 24.99 billion |
| Compound Annual Growth Rate (CAGR) |
5.10% (2024-2032) |
| Base Year |
2023 |
| Market Forecast Period |
2024-2032 |
| Historical Data |
2018 & 2022 |
| Market Forecast Units |
Value (USD Billion) |
| Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
Type, Product Type, Route of the Administration, Application, Distribution Channel, and Region |
| Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered |
The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled |
Solace Nutrition (U.K.), AYMES Nutrition International Ltd. (U.K.), Braun Melsungen AG (Germany), NeoMed (U.S.), Abbott Nutrition (U.S.), Baxter International (U.S.), Danone (France), and others |
| Key Market Opportunities |
Increasing number of Chronic diseases patients |
| Key Market Dynamics |
Rising spending on the development of healthcare infrastructure Rising awareness regarding medical nutrition in developing economies |
Medical Nutrition Market Highlights:
Frequently Asked Questions (FAQ) :
The medical nutrition market size was valued at USD 14.4 Billion in 2023.
The market is projected to grow at a CAGR of 5.1% during the forecast period, 2024-2032.
North America had the largest share in the market
The key players in the market are Solace Nutrition (U.K.), AYMES Nutrition International Ltd. (U.K.), Mead Johnson and Company LLC. (U.S.), and others.
The pediatric nutrition type dominated the market in 2023.
The amino acid solutions had the largest share in the market.
